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WY: An 18-year-old footballer with no previous
signiﬁcant medical history sustained a tendon injury
during a football match. This was repaired success-
fully under general anaesthetic, but the SaO2 (% sat-
uration of haemoglobin) was found to be 78.5% on
air. Following recovery from the injury, he returned
to playing football six times per week while he was
investigated further. Chest X-ray and CTscan demon-
strated three pulmonary arteriovenous malformations
(PAVMs) that were thought to be due to underlying
hereditary haemorrhagic telangiectasia (HHT).
CLS: That would be the most likely cause of the
clinical picture. PAVMs1 affect approximately 1 in
2600 people,2 have usually completed growth by
puberty and frequently result in hypoxaemia.3 The
PAVM vessels provide an anatomic right-to-left
shunt that allows a fraction of pulmonary arterial
blood to bypass the pulmonary capillary bed and
hence gas exchange. Greater shunt ﬂow (as a pro-
portion of cardiac output) results in lower PaO2/
SaO2, but this is frequently asymptomatic. The
majority of patients have underlying HHT, espe-
cially if they have multiple PAVMs.
WY: How was it possible for him to be so
sporty?
CLS: The relevant term for oxygen transport to
the tissues is not the SaO2 or PaO2 (in kPa or
mm Hg), but the arterial oxygen content (CaO2
(mL of oxygen per unit blood volume)). CaO2
depends on the concentration of haemoglobin in
addition to the commonly measured oxygen para-
meters. I would predict that the patient had sec-
ondary polycythaemia at presentation.
WY: Yes, the haemoglobin was 20.9 g/dL and
haematocrit 0.61%.
CLS: So this will have maintained his CaO2, which
we can calculate as SaO2×haemoglobin×1.34/100.
His CaO2 was 22 mL/dL, which is higher than
normal, as seen in 23 athletes with PAVMs, compared
with 121 non-athletic patients with PAVMs and
normal exercise tolerance.3 As discussed elsewhere,1 3
athletic training increases the red cell mass, and it
seems for patients with PAVMs, they may adapt to
meet oxygen demands on exercise. On cardiopulmon-
ary exercise testing of 21 patients with PAVMs,
maximal work rate and oxygen consumption (V[dot]
O2) were no lower in more hypoxaemic patients.
4
WY: But what if the PaO2/SaO2 falls suddenly?
His SaO2 fell by 10% from lying to standing.
CLS: A fall in SaO2 on standing (orthodeoxia) is
common in patients with PAVMs: in a recent series,
75/257 (29%) consecutive patients with PAVMs
demonstrated a fall in SaO2 of at least 2% on
standing.5 Obviously, the bone marrow does not
respond within minutes to hours, and there is
therefore an acute fall in CaO2.
WY: So his CaO2 will have fallen by 2.6 mL/dL—
is this why his pulse rose by 49 bpm on standing?
CLS: In the 257 patients with PAVMs reported
recently, an exuberant postural tachycardia did
appear to be part of the compensatory mechanism
to acute falls in SaO2/CaO2.
5 This evokes similar-
ities with the tachycardic response to blood volume
depletion and/or haemorrhage—similar barorecep-
tor mechanisms may be operating.
WY: Oxygen guidelines6 would recommend sup-
plementary oxygen for an SaO2 of 78.5% at rest.
CLS: Patients with PAVMs do not ﬁt into any of
the groups considered in the normal oxygen guide-
lines. Oxygen supplementation is helpful in the
alleviation of symptoms in hypoxaemic patients
with PAVMs, for example, if they are breathless,
have cardiac symptoms such as angina or palpita-
tions, or describe neurological symptoms. It is
important to remember that there is no rationale to
prescribe oxygen to alleviate pulmonary hyperten-
sion because PAVMs are not associated with alveo-
lar hypoxia, and patients are not at risk of hypoxic
pulmonary hypertension.3 4
WY: Don’t the polycythaemia guidelines7 suggest
that this patient should have been venesected?
CLS: Maybe, but only if you think his PAVMs
meant he should be considered as having a respira-
tory disease, when venesection of the asymptomatic
patient is recommended.
DML: There is evidence venesection may be of
beneﬁt to patients with erythrocytosis secondary to
hypoxic pulmonary disease in terms of effort toler-
ance and neurocognitive function, which mirror
improvement in pulmonary vascular resistance and
cerebral blood ﬂow. This was initially demonstrated
in patients with cor pulmonale. Current guidelines7
recommend venesection is considered if the haem-
atocrit is >0.56 or if there are symptoms of hyper-
viscosity. PAVMs, however, differ from other forms
of hypoxic pulmonary disease due to airﬂow
obstruction or interstitial lung disease.
CLS: The pathology most resembling PAVMs is
cyanotic congenital heart disease for which the poly-
cythaemia guidelines7 only recommend venesection
if the patient describes symptoms of hyperviscosity.
In this case, as the haematocrit was so high (0.61%),
venesection was considered. However, since embol-
isation was scheduled to take place shortly after
review, the decision was deferred until after correc-
tion of hypoxaemia. Venesection is not without risk:
inducing iron deﬁciency by venesection is likely to be
detrimental, not only in terms of increased cardiac
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demands to maintain tissue oxygen delivery but also because iron
deﬁciency is now recognised to be a strong risk factor for paradox-
ical embolic stroke in patients with PAVMs: In a series of 497 con-
secutive patients with CT-proven pulmonary AVMs, the stroke risk
was 4% higher for every mmol/L fall in serum iron, implying
for the same PAVM(s) the stroke risk would approximately
double with serum iron 6 mmol/L compared with mid-normal
range (7–27 mmol/L).8
WY: And stroke prevention was why treatment of this
patient’s PAVMs was recommended. He underwent a series of
embolisation treatments.
JEJ: All three of this young man’s PAVMs had a complex
angiographic anatomy; in other words, each consisted of numer-
ous arteriovenous communications arising from multiple adja-
cent peripheral pulmonary arterial branches. This is opposed to
the more common ‘simple’ anatomy where there is a single
feeding vessel communicating directly with a venous sac. The
successful embolisation of complex lesions is difﬁcult and, in
this case, required three separate procedures in order to occlude
the majority of the abnormal arteriovenous communications
using a combination of Amplatzer vascular plugs and
MR-compatible metallic coils (ﬁgure 1A, B).
Figure 1 Case details. (A) Chest
X-ray pre (left) and 4 years post (right)
embolisation. (B) Angiographic
appearances of the complex pulmonary
arteriovenous malformations pre (left)
and post (right) embolisation using a
combination of coils and Amplatzer
plugs over three embolisation sessions.
(C) Serial SaO2 measured by pulse
oximetry after 7, 8, 9 and 10 min in
each posture. Mean and SEM displayed
at presentation (P), before and after
each embolisation (Emb.), and at
follow-up (FU).
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WY: Four years later, the SaO2 was 95% on air (ﬁgure 1C).
He was about to resume football (which he had stopped playing
for social reasons), but did state “I don’t feel any different – but
then I felt completely ﬁne before.” Why did he feel no better
when his SaO2 was now almost normal?
CLS: You can work this out. What was his haemoglobin on
follow-up?
WY: The haemoglobin had fallen to 15.6 g/dL with normo-
chromic normocytic indices and no evidence of iron deﬁciency.
CLS: The fall in haemoglobin means that the CaO2 was no
higher than at presentation, despite the increased SaO2. Across
71 patients with PAVMs, haemoglobin fell after embolisation
such that several months after embolisation the CaO2 was no
higher despite higher SaO2.
3 At 20 mL/dL, his CaO2 was in fact
a little lower than at presentation, potentially reﬂecting his
reduced sporting training. There are no cardiopulmonary exer-
cise data for him, but data are reported on ﬁve other patients
with PAVMs, exercised before and several months after embol-
isation that increased SaO2 from 88–94% to 94–96%
(p=0.009): there was no difference in perceived dyspnoea,
maximum workload or maximal oxygen consumption (V[dot]
O2) after embolisation. So patients with PAVMs use compensa-
tory processes to preserve oxygen delivery to the tissues, even
on exercise, and reset these after correction of hypoxaemia.3 4 9
WY: Does everyone with PAVM-induced hypoxaemia manage
this well?
CLS: No, not everyone. Concurrent diseases interfere with
the ability to compensate. The most common problems we see
are iron deﬁciency (leading to a spectrum that ranges from
anaemia to ‘just’ impaired polycythaemia/inappropriately
normal haemoglobin2) and/or concurrent cardiorespiratory
disease. Patients with PAVMs and these additional problems
tend to report more dyspnoea, are less able to exercise and are
more likely to report improvements after embolisation.2 Their
symptoms are remarkably similar to those of pure anaemia,
which effectively results in the same problem—it is harder work
to deliver oxygen to the tissues.
In summary, this case illustrates how successfully haemato-
logical and cardiovascular compensations can maintain oxygen
delivery to the tissues in hypoxaemic patients with
PAVMs. Do not forget, however, that patients with PAVMs are
unusual in their ability to compensate for hypoxaemia: the
PAVM results on tolerance of hypoxemia3 4 should not be
extrapolated to other hypoxaemic patients, where more usual
oxygen guidance as used in acute and respiratory medicine
applies.
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